ARCHIVES

FDA Approves Bexxar For Non-Hodgkin’s Lymphoma

This article is from The Cancer Letter archive.

Vol. 26 No. 6 | June 27, 2003

Download PDF Visit The Full Archive

Related Articles

NCAB, DRCCA Board Asked To Consider Dripping All Staff Investigator Salary Support From Core

October 17, 1980

“Sloppy” Searle Studies Described By FDA At Kennedy Hearing; Rauscher “Outraged”

January 23, 1976

ASCO Strategic Plan Seeks To Increase Value to Members, Public

May 24, 2002

Review Of Cancer Center supports Grants Needs Refocus On Science, Advisors Say

October 18, 1996

Tipping Resigned Forom ACS Following Volunteer Discontent

September 27, 1991

Oblimersen Combination Improves CLL Survival

December 28, 2007